BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34624573)

  • 1. LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1.
    Mao J; Qiu H; Guo L
    Biochem Biophys Res Commun; 2021 Nov; 580():74-80. PubMed ID: 34624573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1.
    Gu J; Dai B; Shi X; He Z; Xu Y; Meng X; Zhu J
    Aging (Albany NY); 2021 Sep; 13(17):21743-21757. PubMed ID: 34518440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
    Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.
    Su Z; Chen M; Ding R; Shui L; Zhao Q; Luo W
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
    Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
    J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
    Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766-5p to inhibit lung adenocarcinoma metastasis.
    Zhang W; Bai M; Liu K; Tan J; Ma J; Zhao J; Hou P
    Int J Biochem Cell Biol; 2022 Dec; 153():106317. PubMed ID: 36283586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 9. Long non-coding RNA HCG11 modulates glioma progression through cooperating with miR-496/CPEB3 axis.
    Chen Y; Bao C; Zhang X; Lin X; Huang H; Wang Z
    Cell Prolif; 2019 Sep; 52(5):e12615. PubMed ID: 31310044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
    Hu Z; Zhu L; Zhang Y; Chen B
    Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
    Sun X; Wang R; Tan M; Tian X; Meng J
    Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
    Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
    Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells.
    Li J; Momen-Heravi F; Wu X; He K
    Oral Dis; 2023 Jul; 29(5):2012-2026. PubMed ID: 35467063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma.
    Qiu M; Feng D; Zhang H; Xia W; Xu Y; Wang J; Dong G; Zhang Y; Yin R; Xu L
    Oncotarget; 2016 Mar; 7(13):16012-22. PubMed ID: 26918601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HCG11 inhibited growth and invasion in cervical cancer by sponging miR-942-5p and targeting GFI1.
    Zhang Y; Zhang J; Mao L; Li X
    Cancer Med; 2020 Oct; 9(19):7062-7071. PubMed ID: 32794340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.
    Zhang H; Wang SQ; Wang L; Lin H; Zhu JB; Chen R; Li LF; Cheng YD; Duan CJ; Zhang CF
    Cell Death Dis; 2022 Jul; 13(7):657. PubMed ID: 35902569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
    Liu J; Zheng Z; Zhong J
    J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Fang H; Sun Q; Zhou J; Zhang H; Song Q; Zhang H; Yu G; Guo Y; Huang C; Mou Y; Jia C; Song Y; Liu A; Song K; Lu C; Tian R; Wei S; Yang D; Chen Y; Li T; Wang K; Yu Y; Lv Y; Mo K; Sun P; Yu X; Song X
    Mol Cancer; 2023 Jun; 22(1):99. PubMed ID: 37353784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.